深圳微芯生物科技有限责任公司与美国食品与药品管理局(FDA)毒理研究国家中心近日签署了共同开发美国用于药理研究及毒理研究的表达谱生物芯片及其信息分析平台的协议。这是美国FDA在全球范围内首次与中国生物企业进行合作。 生物芯片是现代生物学和医学研究领域中最高端的研究 Shenzhen Micro-core Biotechnology Co., Ltd. and the National Center for Toxicology Research of the U.S. Food and Drug Administration (FDA) recently signed an agreement to jointly develop a profiling biochip and its information analysis platform for pharmacological research and toxicological research in the United States. This is the first time that the U.S. FDA has cooperated with Chinese biotech companies in the world. Biochip is the most advanced research in modern biology and medical research